|
Toyoda, Mieko; Puliyanda, Dechu P; Amet, Nurmamet et al. (2005) Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients. Transplantation 80:198-205
|
|
Toyoda, Mieko; Petrosyan, Anna; Pao, Andy et al. (2004) Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transplantation 78:1134-8
|
|
Jordan, Stanley C; Tyan, Dolly; Stablein, Don et al. (2004) Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 15:3256-62
|
|
Toyoda, Mieko; Pao, Andy; Petrosian, Anna et al. (2003) Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am J Transplant 3:156-66
|
|
Jordan, S C; Vo, A; Bunnapradist, S et al. (2003) Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 76:631-6
|
|
Jordan, Stanley C; Vo, Ashley; Bunnapradist, Suphamai et al. (2002) Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. Am J Transplant 2:671-3
|
|
Bunnapradist, S; Jordan, S C (2000) The role of cytokines and cytokine gene polymorphism in T-cell activation and allograft rejection. Ann Acad Med Singapore 29:412-6
|
|
Toyoda, M; Petrosian, A; Jordan, S C (1999) Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 68:1311-8
|
|
Jordan, S C; Quartel, A W; Czer, L S et al. (1998) Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 66:800-5
|
